New Treatment for Patients Having Parkinson's Disease

A comparison of two kinds of deep brain stimulation reveals that they are uniformly effectual in enhancing motor function in patients suffering from Parkinson's disease.

Deep brain stimulation entails surgically inserting a device, which sends electrical responses to some parts of the brain. These electrical impulses encourage sections of the brain that contribute to Parkinson's disease.

The electrodes are normally put in one of two targets, the globus pallidus or the subthalamic nucleus. Both of these regions of the brain are linked with motor function.

A group of researchers, several of them from Veterans Affairs facilities, wished to find out whether aiming at the globus pallidus or the subthalamic nucleus generated better outcome for Parkinson's disease patients.

The study is published in the New England Journal of Medicine.

Parkinson's disease is a disorder of the nervous system, which advances over time. The disease leads to the loss of dopamine-producing brain cells.

Dopamine is a chemical manufactured by the brain that is significant for cognitive function and motion. The signs of Parkinson's disease comprise trouble in moving, tremors, and tautness in the arms and legs.

There is no treatment for Parkinson's disease, however, it can be dealt with treatment.

Around 1 million Americans suffer from Parkinson's disease, while 4% of patients are detected before the age of 50.